Business Wire - Techseriesinsight

July 21, 2025
Business Wire
Artificial Intelligence, News

Alix Secures $20M to Disrupt Wealth Transfer with AI

Alix, a first-of-its-kind wealth transfer platform, today announced a $20 million Series A funding round from Acrew Capital, Charles Schwab and Edward Jones Ventures*. Existing investors Initialized Capital, Scribble,...

July 21, 2025
Business Wire
Biotechnology, Healthcare, News

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

Positive high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy demonstrated a...

July 21, 2025
Business Wire
Artificial Intelligence, Data Management Platform, Networking, News

Omdia: Cloud Infrastructure Key to $12.9B Gaming Tech Ecosystem

New analysis from Omdia shows that cloud platforms are at the core of a $12.9bn technology ecosystem underpinning much of the games industry. This ecosystem spans everything from game...

July 21, 2025
Business Wire
Artificial Intelligence, News

Argonne AI x Nuclear Summit Sparks New Tech Collaborations

Artificial intelligence (AI) is rapidly transforming the American economy. It is driving prosperity through advancements in technology, improved manufacturing efficiencies, and enhanced healthcare solutions. To continue this pace of rapid...

July 18, 2025
Business Wire
Healthcare, News

Global Market Access Training for Medical Device Software

The “Global Market Access for Medical Device Software Training Course” training has been added to ResearchAndMarkets.com’s offering. This course will provide a clear understanding of different market access requirements for medical device software....

July 18, 2025
Business Wire
Biotechnology, News

BMS Reveals Reblozyl Phase 3 Results

Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 INDEPENDENCE trial evaluating Reblozyl (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) therapy in adult patients with myelofibrosis-associated anemia receiving red blood...

July 17, 2025
Business Wire
Data Management Platform, Networking, News, Security

Intel 471 Partners with Sumo Logic to Provide Organizations Exceptional Visibility into the Attack Landscape

Intel 471, the premier provider of cyber intelligence-driven solutions worldwide, and Sumo Logic, the leading SaaS Log Analytics Platform, announced a partnership to bring Intel 471’s premier threat intelligence to...

July 17, 2025
Business Wire
Biotechnology, News

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the U.S....

July 17, 2025
Business Wire
Biotechnology, News

PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study

PureTech Health plc A clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (“Seaport”) a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and...

July 17, 2025
Business Wire
Artificial Intelligence, News, Security

Meta.AI Vulnerability Exposed: Prompts Leaked, AppSecure Rewarded $10K

AppSecure, a cybersecurity firm specializing in penetration testing and red teaming, has discovered a critical vulnerability in Meta.AI, Meta’s generative AI chatbot platform. If left unaddressed, the flaw could have...